The “dark” side of terlipressin: a case report of ischemic skin necrosis and review of literature

Abstract Background Terlipressin is a commonly used drug in cirrhotic patients with acute variceal bleed (AVB) due to its vasoconstrictor effects. Ischemic complications are uncommon adverse events associated with worse outcomes. Case presentation We present a case of alcohol-related cirrhosis, who...

Full description

Bibliographic Details
Main Authors: Arpit Shastri, Sweta Rose, Nikhil Vojjala, Naveen Bhagat, Arka De
Format: Article
Language:English
Published: SpringerOpen 2023-07-01
Series:Egyptian Liver Journal
Subjects:
Online Access:https://doi.org/10.1186/s43066-023-00273-9
Description
Summary:Abstract Background Terlipressin is a commonly used drug in cirrhotic patients with acute variceal bleed (AVB) due to its vasoconstrictor effects. Ischemic complications are uncommon adverse events associated with worse outcomes. Case presentation We present a case of alcohol-related cirrhosis, who was started on terlipressin for AVB. However, he developed bilateral lower limb gangrene with ischemic skin necrosis and ultimately succumbed to death. Conclusion Although ischemic adverse events are uncommon with terlipressin, it is important to be aware of these complications as they may be severe and potentially life threatening.
ISSN:2090-6226